Cargando…

Functional expression of human prostaglandin E2 receptor 4 (EP4) in E. coli and characterization of the binding property of EP4 with G(α) proteins

Human prostaglandin E2 receptor 4 (EP4) is one of the four subtypes of prostaglandin E(2) (PGE(2)) receptors and belongs to the rhodopsin-type G protein-coupled receptor (GPCR) family. Particularly, EP4 is expressed in various cancer cells and is involved in cancer-cell proliferation by a G protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Nam Hyuk, Kim, Key-Sun, Shin, Sang Chul, Kim, Eunice Eunkyeong, Yu, Yeon Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749421/ https://www.ncbi.nlm.nih.gov/pubmed/33367116 http://dx.doi.org/10.1016/j.bbrep.2020.100871

Ejemplares similares

Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
por: Chang, Jian, et al.
Publicado: (2015)

Role of EP(2) and EP(4) receptors in airway microvascular leak induced by prostaglandin E(2)
por: Jones, Victoria C, et al.
Publicado: (2016)

Prostaglandin E2 promotes human CD34(+) cells homing through EP2 and EP4 in vitro
por: Wang, Yaqun, et al.
Publicado: (2017)

Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E(2) Activation in Human Podocytes
por: Mangelsen, Eva, et al.
Publicado: (2020)

Opposing effects of prostaglandin E(2) receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
por: Carboneau, Bethany A., et al.
Publicado: (2017)

Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules
por: Vleeshouwers, Ward, et al.
Publicado: (2021)

A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
por: Philipose, Sonia, et al.
Publicado: (2010)

Prostaglandin E(2 )acts via the EP(4 )receptor to inhibit platelet aggregation
por: Philipose, Sonia, et al.
Publicado: (2009)

Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
por: Maini, Alexander A., et al.
Publicado: (2021)

Prostaglandin E(2) Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP(2) and EP(4)
por: Torres-Atencio, Ivonne, et al.
Publicado: (2014)

T cell–intrinsic prostaglandin E(2)-EP2/EP4 signaling is critical in pathogenic T(H)17 cell–driven inflammation
por: Lee, Jinju, et al.
Publicado: (2019)

The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity
por: Yasui, Mika, et al.
Publicado: (2015)

Prostaglandin E(2) receptor EP4 regulates cell migration through Orai1
por: Osawa, Kohei, et al.
Publicado: (2019)

Regulation of prostaglandin EP(1) and EP(4) receptor signaling by carrier-mediated ligand reuptake
por: Chi, Yuling, et al.
Publicado: (2014)

Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients
por: Minatani, Atsushi, et al.
Publicado: (2016)

Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway
por: Hong, Yu Ah, et al.
Publicado: (2017)

Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear
por: Hori, Ryusuke, et al.
Publicado: (2010)

Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
por: Boniface, Katia, et al.
Publicado: (2009)

Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice
por: Hosono, Kanako, et al.
Publicado: (2016)

Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
por: Mançanares, Ana Carolina Furlanetto, et al.
Publicado: (2020)

Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E(2) receptor EP4
por: Hong, Yu Ah, et al.
Publicado: (2017)

Prostaglandin E2 facilitates subcellular translocation of the EP4 receptor in neuroectodermal NE-4C stem cells
por: Davidson, Jennilee M., et al.
Publicado: (2016)

A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration
por: Jin, Yunyun, et al.
Publicado: (2022)

Inhibitory effects of prostaglandin EP(4 )receptors on human eosinophils
por: Luschnig-Schratl, Petra, et al.
Publicado: (2009)

Prostaglandin E(2) promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation
por: Mo, Chenglin, et al.
Publicado: (2015)

Prostacyclin-IP signaling and prostaglandin E(2)-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis
por: Honda, Tetsuya, et al.
Publicado: (2006)

Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway”
por: Hong, Yu Ah, et al.
Publicado: (2017)

LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological Profiles
por: Jin, Yan, et al.
Publicado: (2017)

Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
por: De Paz Linares, Guillermo Antonio, et al.
Publicado: (2021)

Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells
por: Hsu, Hsi-Hsien, et al.
Publicado: (2017)

Prostaglandin E(2) directly inhibits the conversion of inducible regulatory T cells through EP2 and EP4 receptors via antagonizing TGF‐β signalling
por: Goepp, Marie, et al.
Publicado: (2021)

Changing prostaglandin E2 (PGE(2)) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE(2) receptor EP2 and EP4
por: Huang, Qingqing, et al.
Publicado: (2021)

Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties
por: Kundu, Namita, et al.
Publicado: (2013)

Gene expression of prostaglandin EP4 receptor in three canine carcinomas
por: Musser, Margaret L., et al.
Publicado: (2020)

E-type prostanoid receptor 4 (EP4) in disease and therapy
por: Konya, Viktoria, et al.
Publicado: (2013)

The role of the EP receptors for prostaglandin E(2) in skin and skin cancer
por: Rundhaug, J. E., et al.
Publicado: (2011)

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

The Prostaglandin E(2)-EP3 Receptor Axis Regulates Anaplasma phagocytophilum-Mediated NLRC4 Inflammasome Activation
por: Wang, Xiaowei, et al.
Publicado: (2016)

Prostaglandin E(2) mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP(4)
por: Kanno, Takayasu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5gfbd68in867bisqb6o57mcod